AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.984
-0.056 (-5.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 12.21 | 13.64 | 19.79 | 13.68 | 11.15 | |
| Research & Development | 4.09 | 14.18 | 33.05 | 34.75 | 25.73 | |
| Operating Expenses | 16.3 | 27.82 | 52.84 | 48.43 | 36.88 | |
| Operating Income | -16.3 | -27.82 | -52.84 | -48.43 | -36.88 | |
| Other Non Operating Income (Expenses) | -3.51 | -34.29 | -17.19 | 0.29 | -0.14 | |
| EBT Excluding Unusual Items | -19.81 | -62.12 | -70.02 | -48.14 | -37.02 | |
| Legal Settlements | - | - | - | - | -28.97 | |
| Other Unusual Items | -19.41 | 104.12 | 33.39 | -4.42 | 10.35 | |
| Pretax Income | -39.22 | 42.01 | -384.63 | -52.56 | -55.64 | |
| Earnings From Continuing Operations | -39.22 | 42.01 | -384.63 | -52.56 | -55.64 | |
| Net Income | -39.22 | 42.01 | -384.63 | -52.56 | -55.64 | |
| Net Income to Common | -39.22 | 42.01 | -384.63 | -52.56 | -55.64 | |
| Shares Outstanding (Basic) | 10 | 1 | 77 | 2 | 2 | |
| Shares Outstanding (Diluted) | 10 | 1 | 77 | 2 | 2 | |
| Shares Change (YoY) | 1622.66% | -99.25% | 3896.62% | 9.98% | 1813.85% | |
| EPS (Basic) | -3.95 | 77.74 | -4.99 | -27.25 | -31.73 | |
| EPS (Diluted) | -3.95 | 72.93 | -4.99 | -27.25 | -31.73 | |
| Free Cash Flow | -17.31 | -20.29 | -47.83 | -35.89 | -28.6 | |
| Free Cash Flow Per Share | -1.75 | -35.23 | -0.62 | -18.61 | -16.31 | |
| EBITDA | -16.22 | -27.73 | -52.74 | -48.36 | -36.88 | |
| D&A For EBITDA | 0.08 | 0.1 | 0.1 | 0.07 | 0 | |
| EBIT | -16.3 | -27.82 | -52.84 | -48.43 | -36.88 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.